• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症患者的糖尿病和心血管疾病预防。

The prevention of diabetes and cardiovascular disease in people with schizophrenia.

机构信息

Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.

出版信息

Acta Psychiatr Scand. 2015 Aug;132(2):86-96. doi: 10.1111/acps.12443. Epub 2015 May 15.

DOI:10.1111/acps.12443
PMID:25976975
Abstract

OBJECTIVE

Primary prevention of diabetes and cardiovascular disease is an important priority for people with schizophrenia. This review aims to identify lifestyle and pharmacological interventions that reduce diabetes and cardiovascular disease in people with schizophrenia.

METHOD

PubMed and other electronic databases were searched to identify relevant articles.

RESULTS

Lifestyle interventions that focus on diet and physical activity reduce the incidence of diabetes. Similar programmes in people with schizophrenia have led to significant weight loss and may reasonably be expected to reduce diabetes in the long-term. Metformin may be considered when lifestyle change is not feasible or effective. Lifestyle interventions, particularly smoking cessation, are likely to be effective in reducing cardiovascular disease in people with schizophrenia. Although cardiovascular prevention trials with statins have not been performed in people with schizophrenia, similar reductions in cholesterol has been seen as in the general population and statins should be considered for those at high risk. Traditional cardiovascular risk prediction models perform well in identifying those at high cardiovascular risk, but bespoke prediction models using data from people with schizophrenia perform better.

CONCLUSION

Reducing diabetes and cardiovascular disease requires a coordinated and concerted effort from mental and physical health teams working across primary and secondary care.

摘要

目的

预防糖尿病和心血管疾病是精神分裂症患者的重要优先事项。本综述旨在确定可降低精神分裂症患者糖尿病和心血管疾病风险的生活方式和药物干预措施。

方法

检索 PubMed 和其他电子数据库,以确定相关文章。

结果

专注于饮食和体育锻炼的生活方式干预措施可降低糖尿病的发病率。在精神分裂症患者中实施类似的方案已导致显著的体重减轻,并且从长期来看可能合理地降低糖尿病的风险。如果生活方式改变不可行或无效,则可以考虑使用二甲双胍。生活方式干预措施,特别是戒烟,可能会有效降低精神分裂症患者的心血管疾病风险。尽管尚未在精神分裂症患者中进行他汀类药物心血管预防试验,但在一般人群中已观察到类似的胆固醇降低,因此应考虑对高风险人群使用他汀类药物。传统的心血管风险预测模型在识别高心血管风险方面表现良好,但使用来自精神分裂症患者的数据的定制预测模型表现更好。

结论

要降低糖尿病和心血管疾病的风险,需要精神和身体健康团队在初级和二级保健中进行协调一致的努力。

相似文献

1
The prevention of diabetes and cardiovascular disease in people with schizophrenia.精神分裂症患者的糖尿病和心血管疾病预防。
Acta Psychiatr Scand. 2015 Aug;132(2):86-96. doi: 10.1111/acps.12443. Epub 2015 May 15.
2
Effects of lifestyle changes to reduce risks of diabetes and associated cardiovascular risks: results from large scale efficacy trials.生活方式改变对降低糖尿病及相关心血管风险的影响:来自大规模疗效试验的结果。
Obesity (Silver Spring). 2009 Dec;17 Suppl 3:S43-8. doi: 10.1038/oby.2009.388.
3
A meta-review of lifestyle interventions for cardiovascular risk factors in the general medical population: lessons for individuals with serious mental illness.针对普通医疗人群心血管危险因素的生活方式干预的元综述:对严重精神疾病患者的启示
J Clin Psychiatry. 2015 Apr;76(4):e477-86. doi: 10.4088/JCP.13r08657.
4
[Lifestyle intervention for the prevention of cardiovascular disease].[预防心血管疾病的生活方式干预]
Ned Tijdschr Geneeskd. 2005 Nov 19;149(47):2607-12.
5
How can we promote smoking cessation in people with schizophrenia in practice? A clinical overview.我们如何在实践中促进精神分裂症患者戒烟?临床综述。
Acta Psychiatr Scand. 2015 Aug;132(2):122-30. doi: 10.1111/acps.12412. Epub 2015 Mar 6.
6
The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Cardiovascular diseases.《巴基斯坦非传染性疾病预防控制与健康促进国家行动计划——心血管疾病》
J Pak Med Assoc. 2004 Dec;54(12 Suppl 3):S14-25.
7
Promotion of cardiorespiratory fitness in schizophrenia: a clinical overview and meta-analysis.促进精神分裂症患者的心肺适能:临床概述和荟萃分析。
Acta Psychiatr Scand. 2015 Aug;132(2):131-43. doi: 10.1111/acps.12407. Epub 2015 Mar 4.
8
Running for your life: A review of physical activity and cardiovascular disease risk reduction in individuals with schizophrenia.为生命而奔跑:精神分裂症患者体育活动与心血管疾病风险降低的综述
J Sports Sci. 2016 Aug;34(16):1500-15. doi: 10.1080/02640414.2015.1119875. Epub 2015 Dec 2.
9
Review of community-based interventions for prevention of cardiovascular diseases in low- and middle-income countries.基于社区的干预措施在中低收入国家预防心血管疾病的综述。
Ethn Health. 2012;17(6):651-76. doi: 10.1080/13557858.2012.754409. Epub 2013 Jan 9.
10
[Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].[2016年欧洲临床实践心血管疾病预防指南的西班牙文改编版]
Hipertens Riesgo Vasc. 2017 Jan-Mar;34(1):24-40. doi: 10.1016/j.hipert.2016.11.006. Epub 2016 Dec 23.

引用本文的文献

1
Engagement in a virtual group-based walking intervention for persons with schizophrenia: a qualitative study.参与基于虚拟小组的精神分裂症患者步行干预:一项定性研究。
BMC Psychiatry. 2024 Nov 11;24(1):790. doi: 10.1186/s12888-024-06250-9.
2
Relationship between eating attitudes, depression, and insight in schizophrenic patients with and without type 2 diabetes mellitus: a comparative study in Guangdong, China.2型糖尿病合并与未合并精神分裂症患者的饮食态度、抑郁及自知力之间的关系:中国广东的一项对比研究
Front Psychiatry. 2024 Oct 3;15:1477953. doi: 10.3389/fpsyt.2024.1477953. eCollection 2024.
3
Predictors and shared traits of longevity within 1 year before death in patients with schizophrenia receiving long-term care: 3-year retrospective cross-sectional study.
接受长期护理的精神分裂症患者死亡前1年内的长寿预测因素及共同特征:3年回顾性横断面研究。
BJPsych Open. 2024 Oct 8;10(5):e166. doi: 10.1192/bjo.2024.796.
4
Effects of Adapted Physical Activity on White Matter Integrity in Patients with Schizophrenia.适应性体育活动对精神分裂症患者白质完整性的影响。
Brain Sci. 2024 Jul 15;14(7):710. doi: 10.3390/brainsci14070710.
5
The lived experience of severe mental illness and long-term conditions: a qualitative exploration of service user, carer, and healthcare professional perspectives on self-managing co-existing mental and physical conditions.严重精神疾病和长期疾病的生活体验:服务使用者、照顾者和医疗保健专业人员对自我管理共存的精神和身体状况的观点的定性探索。
BMC Psychiatry. 2022 Jul 19;22(1):479. doi: 10.1186/s12888-022-04117-5.
6
Antipsychotic-Related Risks of Type 2 Diabetes Mellitus in Enrollees With Schizophrenia in the National Basic Public Health Service Program in Hunan Province, China.中国湖南省国家基本公共卫生服务项目中精神分裂症患者使用抗精神病药物相关的2型糖尿病风险
Front Psychiatry. 2022 Feb 24;13:754775. doi: 10.3389/fpsyt.2022.754775. eCollection 2022.
7
Risk factors for natural cause mortality in a cohort of 1494 persons with serious mental illness.1494 例严重精神疾病患者自然死因死亡率的危险因素分析。
Psychiatry Res. 2021 Apr;298:113755. doi: 10.1016/j.psychres.2021.113755. Epub 2021 Jan 24.
8
Medication Use and Health Care Utilization After a Cost-sharing Increase in Schizophrenia: A Nationwide Analysis.精神分裂症患者自付费用增加后药物使用和医疗保健利用情况:一项全国性分析。
Med Care. 2020 Sep;58(9):763-769. doi: 10.1097/MLR.0000000000001369.
9
A web-based adapted physical activity program (e-APA) versus health education program (e-HE) in patients with schizophrenia and healthy volunteers: study protocol for a randomized controlled trial (PEPSY V@Si).基于网络的适应性身体活动方案(e-APA)对比精神分裂症患者和健康志愿者的健康教育方案(e-HE):一项随机对照试验(PEPSY V@Si)的研究方案。
Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):325-337. doi: 10.1007/s00406-020-01140-z. Epub 2020 May 26.
10
Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia.首发未用药精神分裂症患者的血糖紊乱、认知缺陷和白质异常
Mol Psychiatry. 2020 Dec;25(12):3220-3230. doi: 10.1038/s41380-019-0478-1. Epub 2019 Aug 13.